In contrast, in patients with low MPO levels at baseline, the severity of CHF and structural remodeling may be less pronounced and, therefore, CRT implantation in these patients might be less beneficial although fulfilling CRT implantation criteria [9, 10]. This evidence concerns the gene MPO and congestive heart failure.